Related Experiment Video

Updated: Aug 30, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse

Anne-Marie Gaben1, Cecile Saucier, Monique Bedin

  • 1INSERM U 482, Hôpital St-Antoine, Paris, France. gaben@adr.st-antoine.inserm.fr

International Journal of Cancer
|November 26, 2003
PubMed

Insights

Rapamycin, an immunosuppressant, halts cell proliferation by blocking early G1 phase progression. It inhibits cyclin-dependent kinase (CDK) activation and reduces p21(WAF1/CIP1) levels, preventing cell cycle entry.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Rapamycin is a potent immunosuppressant that inhibits cell proliferation by arresting the cell cycle at the G1/S transition.
  • While rapamycin affects p70 S6K and Rb phosphorylation, the exact molecular mechanisms remain unclear.
  • Understanding rapamycin's effects on cell cycle regulation is crucial for its therapeutic applications.

Purpose of the Study:

  • To elucidate the precise mechanisms by which rapamycin inhibits cell proliferation in mouse BP-A31 fibroblasts.
  • To investigate the impact of rapamycin on key cell cycle regulators, including cyclins, cyclin-dependent kinases (CDKs), and their inhibitors.
  • To determine the role of p21(WAF1/CIP1) in rapamycin-induced cell cycle arrest.

Main Methods:

  • Synchronization of mouse BP-A31 fibroblasts in G0/G1 phase using serum starvation.
  • Treatment with rapamycin to inhibit G1-phase progression.
  • Analysis of cyclin D1/cdk4 complex assembly and activation.
  • Assessment of Rb phosphorylation levels.
  • Quantification of total and complex-associated p21(WAF1/CIP1) levels.

Main Results:

  • Rapamycin effectively inhibited the entry of synchronized fibroblasts into S phase, with effects localized to early G1.
  • The assembly of cyclin D1/cdk4 complexes was not affected by rapamycin.
  • Rapamycin treatment led to the inhibition of cyclin D1/cdk4 and cyclin E/cdk2 activation, as well as reduced Rb phosphorylation.
  • A significant reduction in both total p21(WAF1/CIP1) and p21(WAF1/CIP1) associated with cyclin D1/cdk4 complexes was observed.

Conclusions:

  • Rapamycin inhibits cell cycle progression at early G1 phase in BP-A31 fibroblasts.
  • The drug's mechanism involves the inhibition of CDK activation and Rb phosphorylation.
  • Rapamycin-induced reduction in p21(WAF1/CIP1) expression is proposed as a key mechanism for inhibiting the CDK cascade and triggering cell cycle arrest.

More Related Videos

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...